MEI Pharma, Inc. , an oncology company focused on the clinical development of novel therapies for cancer, announced today that it plans to offer shares of its common stock in an underwritten public offering.
http://www.freshnews.com/news/861679/mei-pharma-announces-public-offering-of-common-stock
http://www.freshnews.com/news/861679/mei-pharma-announces-public-offering-of-common-stock
No comments:
Post a Comment